Summary Slide.png (70.83 kB)

Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis

Download (70.83 kB)
posted on 16.09.2020 by Stanley B. Cohen, Jeffrey D. Greenberg, James Harnett, Ann Madsen, Timothy W. Smith, David Gruben, Richard Zhang, Tatjana Lukic, John Woolcott, Kimberly J. Dandreo, Heather J. Litman, Taylor Blachley, Anne Lenihan, Connie Chen, Jose L. Rivas, Maxime Dougados

Article full text

The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.